Childhood Maltreatment in the Migraine Patient

Gretchen E. Tietjen, Dawn C. Buse, Stuart A. Collins

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Maltreatment during childhood increases vulnerability to a host of health disorders, including migraine. Putative mechanisms linking maltreatment and migraine include stress-induced dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, as well as disruption of other stress-mediating homeostatic systems, including those involving endocannabinoids, monoamine neurotransmitters, oxytocin, and inflammation. Prolonged elevation of glucocorticoids alters the neural architecture of the limbic system, resulting in the structural as well as functional changes described in both maltreatment and in migraine. Although treatment trials for migraine have not stratified participants by abuse history, strategies, such as cognitive behavioral therapy, which alter stress responsivity, may be particularly effective in this subgroup. Some therapies involving the endocannabinoid, serotonergic, oxytonergic, and inflammatory systems are under investigation for migraine. Anti-epileptic drugs such as valproate and topiramate, which are FDA approved for migraine treatment, are also known to interfere with epigenetic changes induced by stress. Discerning the role for this mechanism in treatment of maltreated migraineurs may introduce another therapeutic avenue.

Original languageEnglish (US)
Article number31
JournalCurrent Treatment Options in Neurology
Volume18
Issue number7
DOIs
StatePublished - 2016

Fingerprint

Migraine Disorders
Endocannabinoids
Therapeutics
Limbic System
Valproic Acid
Cognitive Therapy
Oxytocin
Epigenomics
Glucocorticoids
Neurotransmitter Agents
Inflammation
Health
Pharmaceutical Preparations

Keywords

  • Abuse
  • Adverse childhood experiences
  • Childhood maltreatment
  • Cognitive behavioral therapy
  • Epigenetics
  • Genetics
  • Hypothalamic–pituitary–adrenal axis
  • Inflammation
  • Migraine
  • Oxytocin
  • Serotonin
  • Stress

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Childhood Maltreatment in the Migraine Patient. / Tietjen, Gretchen E.; Buse, Dawn C.; Collins, Stuart A.

In: Current Treatment Options in Neurology, Vol. 18, No. 7, 31, 2016.

Research output: Contribution to journalReview article

Tietjen, Gretchen E. ; Buse, Dawn C. ; Collins, Stuart A. / Childhood Maltreatment in the Migraine Patient. In: Current Treatment Options in Neurology. 2016 ; Vol. 18, No. 7.
@article{7dddcffa7de44d549051a1aec25e62fb,
title = "Childhood Maltreatment in the Migraine Patient",
abstract = "Maltreatment during childhood increases vulnerability to a host of health disorders, including migraine. Putative mechanisms linking maltreatment and migraine include stress-induced dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, as well as disruption of other stress-mediating homeostatic systems, including those involving endocannabinoids, monoamine neurotransmitters, oxytocin, and inflammation. Prolonged elevation of glucocorticoids alters the neural architecture of the limbic system, resulting in the structural as well as functional changes described in both maltreatment and in migraine. Although treatment trials for migraine have not stratified participants by abuse history, strategies, such as cognitive behavioral therapy, which alter stress responsivity, may be particularly effective in this subgroup. Some therapies involving the endocannabinoid, serotonergic, oxytonergic, and inflammatory systems are under investigation for migraine. Anti-epileptic drugs such as valproate and topiramate, which are FDA approved for migraine treatment, are also known to interfere with epigenetic changes induced by stress. Discerning the role for this mechanism in treatment of maltreated migraineurs may introduce another therapeutic avenue.",
keywords = "Abuse, Adverse childhood experiences, Childhood maltreatment, Cognitive behavioral therapy, Epigenetics, Genetics, Hypothalamic–pituitary–adrenal axis, Inflammation, Migraine, Oxytocin, Serotonin, Stress",
author = "Tietjen, {Gretchen E.} and Buse, {Dawn C.} and Collins, {Stuart A.}",
year = "2016",
doi = "10.1007/s11940-016-0415-4",
language = "English (US)",
volume = "18",
journal = "Current Treatment Options in Neurology",
issn = "1092-8480",
publisher = "Current Science, Inc.",
number = "7",

}

TY - JOUR

T1 - Childhood Maltreatment in the Migraine Patient

AU - Tietjen, Gretchen E.

AU - Buse, Dawn C.

AU - Collins, Stuart A.

PY - 2016

Y1 - 2016

N2 - Maltreatment during childhood increases vulnerability to a host of health disorders, including migraine. Putative mechanisms linking maltreatment and migraine include stress-induced dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, as well as disruption of other stress-mediating homeostatic systems, including those involving endocannabinoids, monoamine neurotransmitters, oxytocin, and inflammation. Prolonged elevation of glucocorticoids alters the neural architecture of the limbic system, resulting in the structural as well as functional changes described in both maltreatment and in migraine. Although treatment trials for migraine have not stratified participants by abuse history, strategies, such as cognitive behavioral therapy, which alter stress responsivity, may be particularly effective in this subgroup. Some therapies involving the endocannabinoid, serotonergic, oxytonergic, and inflammatory systems are under investigation for migraine. Anti-epileptic drugs such as valproate and topiramate, which are FDA approved for migraine treatment, are also known to interfere with epigenetic changes induced by stress. Discerning the role for this mechanism in treatment of maltreated migraineurs may introduce another therapeutic avenue.

AB - Maltreatment during childhood increases vulnerability to a host of health disorders, including migraine. Putative mechanisms linking maltreatment and migraine include stress-induced dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, as well as disruption of other stress-mediating homeostatic systems, including those involving endocannabinoids, monoamine neurotransmitters, oxytocin, and inflammation. Prolonged elevation of glucocorticoids alters the neural architecture of the limbic system, resulting in the structural as well as functional changes described in both maltreatment and in migraine. Although treatment trials for migraine have not stratified participants by abuse history, strategies, such as cognitive behavioral therapy, which alter stress responsivity, may be particularly effective in this subgroup. Some therapies involving the endocannabinoid, serotonergic, oxytonergic, and inflammatory systems are under investigation for migraine. Anti-epileptic drugs such as valproate and topiramate, which are FDA approved for migraine treatment, are also known to interfere with epigenetic changes induced by stress. Discerning the role for this mechanism in treatment of maltreated migraineurs may introduce another therapeutic avenue.

KW - Abuse

KW - Adverse childhood experiences

KW - Childhood maltreatment

KW - Cognitive behavioral therapy

KW - Epigenetics

KW - Genetics

KW - Hypothalamic–pituitary–adrenal axis

KW - Inflammation

KW - Migraine

KW - Oxytocin

KW - Serotonin

KW - Stress

UR - http://www.scopus.com/inward/record.url?scp=84971201144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84971201144&partnerID=8YFLogxK

U2 - 10.1007/s11940-016-0415-4

DO - 10.1007/s11940-016-0415-4

M3 - Review article

VL - 18

JO - Current Treatment Options in Neurology

JF - Current Treatment Options in Neurology

SN - 1092-8480

IS - 7

M1 - 31

ER -